Bateman, E. D.; O'Byrne, P. M.; Buhl, R. et al.
Roflumilast for asthma: Weighing the evidencePULMONARY PHARMACOLOGY & THERAPEUTICS. Bd. 35. 2015 S. S1-S3
Hess, G.; Keller, U.; Scholz, C. W. et al.
Safety and efficacy of Temsirolimus in combination with Bendamustine and Rituximab in relapsed mantle cell and follicular lymphomaLEUKEMIA. Bd. 29. H. 8. 2015 S. 1695-1701
Bai, Chunxue; Buhl, Roland; Lee, Sang Haak et al.
SAFETY OF ONCE-DAILY TIOTROPIUM PLUS OLODATEROL VIA THE RESPIMAT (R) IN EAST ASIAN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)RESPIROLOGY. Bd. 20. 2015 S. 55-55
Weidenthaler-Barth, B.; Steinbrink, K.; Kuemmel, A. et al.
Sarcoidosis. Organ involvement, diagnosis, current treatmentHAUTARZT. Bd. 66. H. 7. 2015 S. 549-561
Muther, Susanne K.; Werner, Anke; Amann, Eva et al.
Signaling via protein kinase B/Akt is involved in activation-induced expression of the cationic amino acid transporter hCAT-1 in human primary T lymphocytesAMINO ACIDS. Bd. 47. H. 8. 2015 S. 1623-1623
Marg, K. R.; Loquai, C.; Rudolph, B. et al.
Sonographic evaluation of lymph node morphology after intranodal vaccination with an RNA-based vaccine in patients with malignant melanomaJOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT. Bd. 13. 2015 S. 33-33
Merz, Maximilian; Salwender, Hans; Haenel, Mathias et al.
Subcutaneous versus intravenous bortezomib in two different induction therapies for newly diagnosed multiple myeloma: an interim analysis from the prospective GMMG-MM5 trialHAEMATOLOGICA. Bd. 100. H. 7. 2015 S. 964-969
Muders, Pia; Zahrt-Omar, Corinna Aruna; Bussmann, Sonja et al.
Support for families of patients dying with dementia: A qualitative analysis of bereaved family members' experiences and suggestionsPALLIATIVE & SUPPORTIVE CARE. Bd. 13. H. 3. 2015 S. 435-442
Kang, Biao; Okwieka, Patricia; Schoettler, Susanne et al.
Tailoring the stealth properties of biocompatible polysaccharide nanocontainersBIOMATERIALS. Bd. 49. 2015 S. 125-134
Hess, Georg; Keller, Ulrich; Atta, Johannes et al.
Temsirolimus in Combination with Bendamustine and Rituximab for the Treatment of Relapsed Mantle Cell and Follicular Lymphoma: Report on an Ongoing Phase I/II TrialBLOOD. Bd. 126. H. 23. 2015